Company Overview and News

147
Should You Buy Facebook (FB) Stock At New All-Time High?

28m zacks
Facebook (FB - Free Report) stock climbed over 2.2% on Wednesday to touch a new all-time high after the company announced that its Instagram platform rolled out a new long-form video feature in a move that will see it compete more directly against the likes of Google’s (GOOGL - Free Report) YouTube. Cleary, it didn’t take many investors too long to move on from Facebook’s data scandal woes. But let’s take some time to see if Facebook stock seems like a buy at the moment.
FB BBW TWTR SNAP

111
Instagram expands into long videos, will compete with YouTube

6h moneycontrol
Facebook Inc-owned social network Instagram launched a mobile app on Wednesday dedicated to user-generated videos up to an hour long, intensifying the competition for consumers' time among ad-supported streaming services such as YouTube.
ICICIBANK GOOGL 532174 IBN GOOG SNAP

127
Instagram Launches Long-Form Video: Should YouTube Worry?

12h zacks
After hitting one billion users, popular social media platform Instagram, which is owned by Facebook (FB - Free Report) , launched a new feature and standalone app called IGTV. The app will strive to be mobile friendly, simple and curated.
FB GOOGL SNAP

104
UPDATE 1-Instagram expands into long videos, will compete with YouTube

17h reuters
SAN FRANCISCO (Reuters) - Facebook Inc-owned (FB.O) social network Instagram said on Wednesday it was adding a section dedicated to long-form video, expanding beyond its photo-sharing app roots in a competition among streaming services for consumers’ time.
GOOGL GOOG SNAP

123
Instagram Adds Mobile TV Feature After Reaching 1 Billion Users - Bloomberg

17h bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
FB SNAP

171
HUYA Stock Requires Patience Under Trump Tariffs

18h investorplace
It has been barely over a month since its initial public offering, and already, HUYA (NYSE:HUYA) is making a huge impact. The IPO scene is a rough one to call, with popular names like Blue Apron (NYSE:APRN) and Snap (NYSE:SNAP) producing disappointing performances. Can upstart HUYA stock break this trend?
APRN JD HUYA SNE BIDU SNAP

144
Facebook stock tops $200 for the first time - MarketWatch

21h marketwatch
Shares of Facebook Inc. FB, +2.59% are trading at record levels and topped $200 for the first time in Wednesday trading. If the gains hold, this would mark Facebook's third record high in the past week. Shares are now up more than 45% since late March, when news about the company's Cambridge Analytica scandal first broke. The stock's rise Wednesday comes on a strong day for shares of Twitter Inc. TWTR, +3.
FB TWTR SNAP

109
Wednesday’s Vital Data: Netflix, General Electric and Snap Inc.

21h investorplace
U.S. stock futures are headed higher this morning. Wall Street is digesting yesterday’s trade-war induced plunge, with bargain hunters picking through the fallout. The situation remains precarious, however, with President Donald Trump calling for $200 billion in new tariffs on Chinese imports, and China promising to retaliate in kind.
GE GEC GNE NFLX SNAP

107
Will SurveyMonkey Be the Next Big Confidential IPO?

2018-06-19 247wallst
SurveyMonkey has announced that its parent company, SVMK, has submitted a draft registration statement S-1 form with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO). This is a confidential filing that is not readily available.
SQ DBX SQNXF ZS DOCU SNAP

167
3 Stocks to Buy on Weakness | InvestorPlace

2018-06-19 investorplace
The key to making money by buying stocks low is finding good companies in high-growth sectors whose shares have dropped because of temporary factors. In other words, investors, particularly longer-term investors, should try to find stocks to buy on weakness that will probably prove to be temporary.
FB DB WYNN NEE.PRI NEE.PRJ DQ NEE.PRC TWTR NEE.PRQ NEE.PRR DIS NEE SNAP

102
How to Profit From the Inevitable End to Snap Inc’s Comeback

2018-06-19 investorplace
The Snap Inc (NYSE:SNAP) boom/bust cycle I’ve talked about repeatedly this year remains in full swing. After an impressive surge off all-time lows, it’s time once again for SNAP stock to reverse course.
P SNAP

124
Snap CEO Spiegel Deflects Facebook Threat; Says ‘Innovators Win’ - Bloomberg

2018-06-18 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
FB SNAP

209
Is Snap Inc Making the Same Mistake Facebook, Inc. Did?

2018-06-18 investorplace
Snap Inc (NYSE:SNAP) is seemingly taking a big risk. On Thursday, Snap rolled out Snap Kit, a developer kit that allows users to log in to other apps via its platform. That, of course, also allows third-party developers access to the data of Snapchat users.
FB GOOGL TWTR TSLA NFLX GOOG SNAP

259
A Deal with SNAP Could Be Just What Pandora Media Inc. Stock Needed

2018-06-17 investorplace
This week, music streaming platform Pandora Media Inc. (NYSE:P) made its way 10% higher after the company announced a new social media partnership with Snap Inc. (NYSE:SNAP). The deal will allow Snapchat users to share their favorite songs with friends on the app and has been praised as an important step forward for Pandora stock.
SPOT AAPL P SNAP

100
U.S. Tech Stocks Show Clear Signs Of Irrational Behavior

2018-06-16 seekingalpha
What we have seen in the past few weeks in the tech sector are unequivocal signs of irrational behavior starting to spread. Let’s forget about the Nasdaq reaching new highs, which doesn’t tell us much per se, and let’s focus on how single stocks have behaved recently.
DBX TWX NFLX TWC SNAP

SNAP : Snapchat Stock Analysis and Research Report

2017-10-16 - Asif

Snap Inc. is a camera company. Snap believe that reinventing the camera represents Its greatest opportunity to improve the way that people live and communicate. Its products empower people to express themselves, live in the moment, learn about the world, and have fun together. Its flagship product, Snapchat, is a camera application that was created to help people communicate through short videos and images. The company call each of those short videos or images a Snap. On average, 173 million people use Snapchat daily, and over 3.0 billion Snaps are created every day. On average, its users visit Snapchat more than 20 times per day and spend over 30 minutes on Snapchat every day. Trends in User Metrics User Engagement The company define a Daily Active User as a registered Snapchat user who opens the Snapchat application at least once during a defined 24-hour period. The company measure average Daily Active Users for a particular quarter by calculating the averag...

Related Articles

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

PRTO: Proteon Therapeutics Analysis and Research Report

2018-06-11 - Asif

Overview Proteon Therapeutics is a late-stage biopharmaceutical company focused on the development of novel, first-in-class pharmaceuticals to address the needs of patients with renal and vascular disease. The company's product candidate, vonapanitase, is a recombinant human elastase that Proteon Therapeutics is developing to improve vascular access outcomes in patients with chronic kidney disease, or CKD, undergoing or planning for hemodialysis, a lifesaving treatment that cannot be conducted without a functioning vascular access. The company believe data from its completed Phase 2 and Phase 3 clinical trials of vonapanitase support that a one-time, local application of investigational vonapanitase during surgical creation of a radiocephalic fistula for hemodialysis may improve fistula use for hemodialysis and secondary patency (time to fistula abandonment), thereby improving patient outcomes and reducing the burden on patients and the healthcare system. Arteriovenous fistu...

GALE: Galena Biopharma Analysis and Research Report

2018-06-11 - Asif

Overview Galena Biopharma is a clinical-stage biopharmaceutical company focused on novel cancer immunotherapeutics for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, or GPS, is a cancer i unotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, that targets the Wilms tumor 1, or WT1, protein, which is present in 20 or more cancer types. Based on its mechanism of action as a directly immunizing agent, GPS has the potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic, or blood, cancers and solid tumor indications. Phase 2 clinical trials for GPS have been completed and Galena Biopharma has planned Phase 3 clinical trials (pending funding availability) for two indications, acute myeloid leukemia, or AML, and malignant pleural mesothelioma, or MPM. GPS is also in development as a potential treatment for multiple myeloma, or MM, and ovarian can...

Silicon Investor Message Boards

This table lists all message boards related to SNAP / Snapchat, Inc. on message board site Silicon Investor.

Snap, Inc. SNAP
SNPD - Snap u0027Nu0027 Sold Corporation Snap2 Corporation (OTC BB: SSNP)
CUSIP: 83304A106